These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20978048)

  • 1. Dabigatran v warfarin. Compare with higher standard.
    Edwards D
    BMJ; 2010 Oct; 341():c5984. PubMed ID: 20978048
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
    Khoo CW; Lip GY
    Expert Opin Pharmacother; 2010 Mar; 11(4):685-7. PubMed ID: 20105114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should dabigatran replace warfarin for stroke prevention in AF?
    Drug Ther Bull; 2011 Oct; 49(10):114-7. PubMed ID: 21994438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran in clinical practice.
    Nagarakanti R; Ellis CR
    Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
    Belavic JM
    Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dabigatran: beyond the RE-LY study].
    García Alegría J
    Rev Clin Esp; 2012 Mar; 212 Suppl 2():1-3. PubMed ID: 23117715
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin: is the end nigh? Please?
    Neilson RF
    J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766
    [No Abstract]   [Full Text] [Related]  

  • 8. What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?
    Khan M; Raza E; Kamal AK
    J Pak Med Assoc; 2011 Jun; 61(6):612-3. PubMed ID: 22204226
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of anticoagulation control in atrial fibrillation.
    Lane DA; Lip GY
    Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
    [No Abstract]   [Full Text] [Related]  

  • 10. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
    Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
    Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
    Grave S
    Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study].
    Liakishev AA
    Kardiologiia; 2009; 49(10):75-6. PubMed ID: 19845524
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
    Paikin JS; Haroun MJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.
    Schwartz NE; Albers GW
    Stroke; 2010 Jun; 41(6):1307-9. PubMed ID: 20395603
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation: improve care quality or use new alternatives?
    You JH
    Lancet; 2011 Feb; 377(9764):464-5; author reply 465. PubMed ID: 21296230
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A; Bailey C; Abdelhafiz AH
    Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drug in atrial fibrillation--how does it function in regular health care?].
    Holmström M; Johnsson H; Lärfars G; Malmström R; Hjemdahl P
    Lakartidningen; 2009 Nov 4-12; 106(45):3019-20. PubMed ID: 19998831
    [No Abstract]   [Full Text] [Related]  

  • 18. Dabigatran etexilate in people with atrial fibrillation.
    Raju NC; Hankey GJ
    BMJ; 2010 Jul; 341():c3784. PubMed ID: 20671015
    [No Abstract]   [Full Text] [Related]  

  • 19. Do ingredients make the difference?: finding the best cocktail of an anticoagulant with antiplatelets.
    Sinnaeve PR; Van de Werf F
    Circulation; 2013 Feb; 127(5):566-8. PubMed ID: 23271795
    [No Abstract]   [Full Text] [Related]  

  • 20. Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
    Ma TK; Yan BP; Lam YY
    Pharmacol Ther; 2011 Feb; 129(2):185-94. PubMed ID: 20920530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.